ERBB2 and breast cancer: Specifically, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) breast cancer subtype has the highest incidence rate per 100,000 across age groups [4], and the majority of HR+, HER2− subtypes occur in older women [5].